The artificial lung (AL) is a prosthetic gadget that transfers oxygen to the blood and eliminates carbon dioxide from the blood. Artificial Lungs is expected to replace a fair share of the functions that the natural lung performs in human body in near future. Along with utilizing conventional procedures (upper bar), artificial lung (AL) support is initiated when the other treatment options, including mechanical ventilation (MV), are of no help in improving the patient's condition. Respiratory assistance gadgets, like artificial lungs, could at last get practically importance equivalent to ventricular aiding gadgets.
Corona virus flare-up internationally brought about expansion sought after for artificial lung that goes about as an extrinsic supportive system imparting oxygenation of blood and elimination of carbon dioxide from the blood in patients that fail to do it naturally. Patients suffering from End-stage lungs illness, specifically chronic obstructive pulmonary infections (COPD) patients, serious pulmonary hypertension(PAH), Intense respiratory pain disorder (ARDS) are prescribed Artificial lungs. Massive number of populations is expected to become a part of active consumer base for artificial lungs market due to corona virus outbreak and its complications related to respiratory illnesses worldwide.
North America and Asia pacific region is assessed to hold huge market size over the estimated time frame of 2023-2032 due to the thriving cardinal number of cardiovascular sicknesses, fast-paced groundbreaking transformations in artificial lungs research, expanding attentiveness among the population, and the developing inclination towards negligibly intrusive methods and faster recovery expectations. In this way, the developing number of cardiovascular illnesses is driving the artificial lungs market in North American region segment.
Global Artificial Lungs Market Value Share Analysis, by Geography (2022)
The report titled “Global Artificial Lungs Market - Global Market Share, Trends, Analysis and Forecasts, 2023-2032”, wherein 2021 is historic period, 2022 is the base year, and 2023 to 2032 is forecast period.
Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the Global Artificial Lungs Market. Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market.
The global artificial lungs market is segmented based on Product type, Application type and geography. Based on product type, it is bifurcated into Single Roller Pump Heart Lung Machines, Double Roller Pump, Heart Lungs Machines, Bubble artificial Lung, Membrane Artificial Lung. Based on application type, this market is categorized into Cardiac Surgery, Lung Transplant Operation, Acute Respiratory Failure Treatment, Others. Based on geography, the Global Artificial Lungs Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America is sub-segmented into the United States, Canada, and Rest of North America. Europe is sub-segmented into Germany, United Kingdom, Italy, France, Spain, and Rest of Europe. Asia Pacific is sub-segmented into China, Japan, India, Australia, and Rest of Asia Pacific. Middle East & Africa is sub-segmented into Saudi Arabia, UAE, South Africa and Rest of Middle East & Africa. South America is sub-segmented into Brazil and Rest of South America.
The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment and would identify the segment of the company focusing on Global Artificial Lungs Market. Further, market share of prominent companies in the global artificial lungs market would also be estimated.
The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, swot analysis, and research and development focus of all the Artificial Lungs companies. The Global Artificial Lungs Market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution.
Product portfolio would focus on all the products under the Artificial Lungs business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the global artificial lungs market.
The key players of the global artificial lungs market are ALung Technologies, Breethe, Haemair, Lung Biotechnology PBC, McGowan Institute for Regenerative Medicine, MedArray, Michigan Critical Care Consultants, Miromatrix Medical, The Charles Stark Draper Laboratory, Xenios.
Global Artificial Lungs Market Key Segments:
By Product Type
By Application Type
By Region
Massive number of populations is expected to become a part of active consumer base for artificial lungs market due to corona virus outbreak and its complications related to respiratory illnesses worldwide.
The developing number of cardiovascular illnesses is driving the artificial lungs market in North America and Asia pacific region segment. Thriving cardinal number of cardiovascular sicknesses, fast-paced groundbreaking transformations in artificial lungs research, expanding attentiveness among the population, and the developing inclination towards negligibly intrusive methods and faster recovery expectations.
Based on product type, the artificial lungs market is segmented into Single Roller Pump Heart Lung Machines, Double Roller Pump, Heart Lungs Machines, Bubble artificial Lung and Membrane Artificial Lung.
Major players operating in the global artificial lungs market include ALung Technologies, Breethe, Haemair, Lung Biotechnology PBC, McGowan Institute for Regenerative Medicine, MedArray, Michigan Critical Care Consultants, Miromatrix Medical, The Charles Stark Draper Laboratory and Xenios.
Copyright © 2024 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved